Results 221 to 230 of about 527,356 (286)

Efficacy and Safety of SGLT2 Inhibitors in Patients With Genetic Lipodystrophy: A Real‐Life Experience From a National Reference Network

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10318-10329, November 2026.
ABSTRACT Aim Lipodystrophy syndromes are rare diseases with metabolic and cardiovascular consequences. This study explores the metabolic and renal effects of sodium‐glucose cotransporter 2 inhibitors (SGLT2i) in patients with genetic lipodystrophy. Patients and Methods Patients with familial partial lipodystrophy (n = 57) or congenital generalised ...
Léna Robert, Ines Belalem, Corinne Vigouroux, Hippolyte Dupuis, Marie Christine Vantyghem, Mathilde Simonson, Estelle Nobecourt, Héléna Mosbah, Sophie Beliard, Stéphanie Jellimann, Sonja Janmaat, Camille Vatier, Sophie Lamothe   +12 more
wiley   +1 more source

Mass-forming ischemic colitis mimicking colon cancer: A case report of early repeat colonoscopy. [PDF]

Medicine (Baltimore)
Baek HS, Seo SY.
europepmc   +1 more source

Quality of Diabetes Care Among Older Adults in Germany—Results of the Study on Health of Older People 2022/2023 Compared With Previous National Health Surveys

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10018-10027, November 2026.
ABSTRACT Aims The study aims (1) to evaluate the quality of diabetes care considering guideline‐recommended medical therapies, cardiometabolic factors, and self‐management of health behaviours among older adults with diabetes in Germany, and (2) to examine time trends.
Yong Du, Giselle Sarganas, Beate Gaertner, Maike Buchmann, Judith Fuchs, Hannelore Neuhauser, Christin Heidemann   +6 more
wiley   +1 more source

Severe Myocardial Bridging Without Obstructive Coronary Artery Disease Presenting as Non-ST-Elevation Myocardial Infarction: A Management Challenge in Sinus Bradycardia. [PDF]

Cureus
Bettinotti BG, Gomez JG, Sanku K, Loescher V, Escolar E.   +4 more
europepmc   +1 more source

Omnipod 5 Delivers Superior Economic Value Compared to Multiple Daily Injections: A Cost‐Effectiveness Analysis in Adults With T1D From a Payer Perspective in Sweden

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10142-10152, November 2026.
ABSTRACT Aim Analyse the cost‐effectiveness of the Omnipod 5 automated insulin delivery system versus multiple daily injections (MDI) with continuous glucose monitoring for type 1 diabetes among adults in Sweden. Methods Cost‐effectiveness was analysed with the IQVIA Core Diabetes Model (version 10.0) taking the perspective of the payer in Sweden ...
Johan Jendle, Colin Hopley, Anuj Narang, Raffaele Scarica, Helena Hellerstedt, Melanie Littlewood   +5 more
wiley   +1 more source

Recurrent Angina in Apical Hypertrophic Cardiomyopathy Associated With Myocardial Bridging of the Posterior Descending Artery. [PDF]

Cureus
Shah MG, Batta Y, Fabrizio C.
europepmc   +1 more source

Initiation of SGLT2 Inhibitors Versus DPP‐4 Inhibitors in Metformin Users and Risk of Incident Depression: A Nationwide, Claims‐Based Active‐Comparator New‐User Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10765-10779, November 2026.
ABSTRACT Aims To examine the association between initiation of sodium‐glucose cotransporter‐2 (SGLT2) inhibitors and risk of incident depression compared with dipeptidyl peptidase‐4 (DPP‐4) inhibitors among adults with newly diagnosed Type 2 diabetes receiving metformin.
Sangwoo Park, Seogsong Jeong, Hye Jun Kim, Dae Ho Lee, Soo Jung Choi, Sang Min Park   +5 more
wiley   +1 more source

Complex MINOCA With Myocardial Bridge, Vasospasm, and Microvascular Dysfunction in an HCM Patient. [PDF]

JACC Case Rep
Wong A, Muuse J, Iyengar A, Bhatia A, Quesada O, Henry TD.   +5 more
europepmc   +1 more source

A Semi‐Interpretable Multimodal Model Combining Electronic Health Records and Chest X‐Rays for COVID‐19‐Related Death Prediction

Expert Systems, Volume 43, Issue 11, November 2026.
ABSTRACT Purpose Prognostic models can benefit from integrating heterogeneous data sources. While deep learning‐based multimodal models often improve predictive performance, their limited interpretability remains a barrier to clinical adoption. Moreover, achieving robust generalization with such models typically requires large and diverse datasets ...
Lander Rodriguez‐Idiazabal, Jose M. Quintana, Javier Del Ser, Jose Javier Echevarria‐Uraga, Maria Jose Legarreta, Nere Larrea, Fernando García‐García, Irantzu Barrio   +7 more
wiley   +1 more source

Stratifying Cardiovascular Risk in Patients With HCC Receiving Atezolizumab/Bevacizumab: A Comparison of ESC and CARDIOSOR Scores

Liver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background & Aims The management of comorbidities has become increasingly relevant in unresectable hepatocellular carcinoma (uHCC) as immunotherapy prolongs survival. Atezolizumab plus bevacizumab (AB) is a standard first‐line option, but bevacizumab carries a risk of cardiovascular toxicities.
Bernardo Stefanini, Lorenza Rimassa, Massimo Iavarone, Giuseppe Cabibbo, Fabio Marra, Caterina Vivaldi, Andrea Dalbeni, Francesca Romana Ponziani, Andrea Palloni, Sara Lonardi, Lorenzo Lani, Piera Federico, Gianluca Svegliati‐Baroni, Tiziana Pressiani, Luca Ielasi, Chiara Mazzarelli, Stefania De Lorenzo, Rodolfo Sacco, Mariangela Bruccoleri, Ciro Celsa, Alessio Mastro, Gianluca Masi, Alessandra Auriemma, Leonardo Stella, Pierluigi Toniutto, Rosanna Villani, Chiara Deiana, Sara Ascari, Mariarosaria Marseglia, Alessandro Granito, Fabio Piscaglia, Francesco Tovoli, on behalf of the ARTE Study Group, Maria Boe, Andrea De Sinno, Federico Ravaioli, Eleonora Alimenti, Lorenzo Canova, Anna Perna, Marco Vicardi, Leonardo A. Natola, Aldo Filice, Filippo Cattazzo, Federica Carlino, Giulia Grassetti, Lucia Cerrito, Francesco Santopaolo, Maria Pallozzi, Maurizio Pompili, Antonio Gasbarrini, Alessio Quartararo, Sofia Calascibetta, Federica Tosi, Arianna Toscano, Claudia Campani, Elisa Pellegrini   +55 more
wiley   +1 more source